Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.46 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368621 | 1.00 | MAOB (0.47) | MAOBCYP1B1CXCL12EPHX2MAOA | |
| SCHEMBL368229 | 0.84 | TNFRSF1A (0.49) | MAOBCYP1B1MAOACYP1A1CYP2D6 | |
| SCHEMBL368230 | 0.84 | TNFRSF1A (0.49) | MAOBCYP1B1MAOACYP1A1CYP2D6 | |
| SCHEMBL370065 | 0.80 | EPHX2 (0.50) | MAOBCYP1B1EPHX2CYP1A2CYP2D6 | |
| SCHEMBL370064 | 0.80 | EPHX2 (0.50) | MAOBCYP1B1EPHX2CYP1A2CYP2D6 | |
| SCHEMBL1390469 | 0.78 | EPHX2 (0.45) | MAOBCYP1B1EPHX2MAOACYP1A1 | |
| SCHEMBL371063 | 0.78 | EPHX2 (0.45) | MAOBCYP1B1EPHX2MAOACYP1A1 | |
| SCHEMBL368684 | 0.78 | EPHX2 (0.45) | CYP1B1EPHX2CYP1A1 | |
| SCHEMBL368685 | 0.78 | EPHX2 (0.45) | CYP1B1EPHX2CYP1A1 | |
| SCHEMBL15748355 | 0.74 | SNCA (0.53) | MAOBCYP1B1CXCL12MAOAABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2593426-B1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | HOFFMANN LA ROCHE (CH) | 2014-08-20 | — | — | EP | disclosed |
| US-8765730-B2 | 1-hydroxyimino-3-phenyl-propanes | Hoffmann-La Roche Inc (US) | 2014-07-01 | — | — | US | disclosed |
| EP-2593426-A1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | F.HOFFMANN-LA ROCHE AG (CH) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012007365-A1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-19 | — | — | WO | disclosed |
| US-20120010190-A1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010190-A1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | GPBAR1, GPR119, ADRB1 | MAOB 1814/4885CYP1B1 84/4885CXCL12 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.